BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

PolyActiva Reports Positive Glaucoma Implant Trial in Australia

Melbourne ophthalmology company PolyActiva is developing a unique biodegradable ocular implant that provides 6 months of sustained drug deli...

November 06, 2023 | News

New report quantifies the impact of R&D Tax Incentive (RDTI) in Australia’s life sciences sector

The newly-launched ‘Economic impact of the Research & Development Tax Incentive for the biotech industry’, report has quantified the far-re...

November 01, 2023 | News

AusBiotech 2023 kicks off in Brisbane with 1,200 delegates representing global life science ecosystem

Held in Brisbane from 1-3 November, Australia’s biggest week in biotech features its flagship event, AusBiotech 2023, which today launches with more ...

November 01, 2023 | News

AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech

Australia’s biggest week is officially underway, with AusBioInvest 2023 kicking off today in Melbourne to an audience of investors and life sci...

October 30, 2023 | News

Australia's Certa Therapeutics: FT011 Granted US FDA Orphan Drug Status for Systemic Sclerosis

Orphan Drug Designation is granted by the FDA to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 pe...

October 24, 2023 | News

Avance Clinical Briefs 45 Korean Biotechs on Global Drug Development

Dt & SanoMedics Chairman, Charles Park (Park, Chae Gyoo) and Avance Clinical CEO Yvonne Lungershausen co-hosting the Global Clinical Trial Strategy...

October 23, 2023 | News

Cameron Smith Appointed as Chief Business Development Officer for Agilex Biolabs

Cameron brings a wealth of experience in the Bioanalytical field, with a particular focus on Toxicology. His extensive knowledge and global market expertis...

October 17, 2023 | News

Specialised Therapeutics Secures Exclusive License for Novel Ovarian Cancer Treatment from CanariaBio

First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progress...

October 13, 2023 | News

EQT's Acquisition: VetPartners, Key Animal Health Provider in Australia and New Zealand

EQT to acquire VetPartners, the leading provider of veterinary and animal health services across a network of 267 general practice clinics and specialty ...

October 12, 2023 | News

CSL Inks Renewable Power Deal with AGL for Australian Manufacturing

The agreement will significantly advance CSL's Scope 1 & 2 emissions reductions with all electricity used by CSL's Australian manufacturing sites ...

October 12, 2023 | News

Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test

This test employs Droplet Digital PCP (ddPCR) technology to analyze POLE gene mutations in endometrial cancer patients, facilitating the detection of genet...

October 12, 2023 | News

Monash University Sets Australian Standard with Groundbreaking Diabetes Precision Medicine Report.

In a significant development, a new international consensus report on precision medicine in diabetes prevention and care has been released in the renowned ...

October 11, 2023 | News

Australia's First Cu-67 SAR-Bombesin Prostate Cancer Trial Patient Treated

COMBAT, which derives from "Copper-67 SAR-Bombesin in metastatic castrate resistant prostate cancer (NCT05633160)1 is a dose escalation and co...

October 04, 2023 | News

Bionomics Reports Positive Phase 2b Results for BNC210 in Post-Traumatic Stress Disorder Trial

ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. St...

September 29, 2023 | News

Stay Connected